Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04637009
Title A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Astex Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.